Felipe Martinez

Felipe Martínez

FESC FACC

National University of Cordoba, Cordoba, AR

  • Radcliffe
  • OrcidID

Research areas

Hypertension

Heart Failure

Biography

Emeritus Professor of Medicine - Cordoba National University
Director - Instituto DAMIC-Fundación Rusculleda, Córdoba, Argentina
Fellow of the European Society of Cardiology (FESC)
Fellow of the American College of Cardiology (FACC)
Past President - International Society of Cardiovascular Pharmacology

Dr Felipe Martínez is on the Editorial Board of European Cardiology Review.

Read more

Media

APSC Journal Club: Landmark Trials of SGLT2 Inhibitors in HFrEF

Jonathan Yap, Wishnu Aditya, Julian Loh, et al

Watch time: 1h 18m 6s
Sodium–Glucose Co-transporter 2 Inhibitors in Heart Failure: Recent Data and Implications for Practice

Giuseppe Rosano, David Quek, Felipe Martínez, et al

AHA 2019 - DAPA-HF Treatment According to Age

Felipe Martínez,

Watch time: 6m 9s

Andrew JS Coats, Carolyn Lam, Felipe Martínez, et al

Watch time: 57m 59s (6 videos)
DAPA-HF: Clinical trial design rationale

Felipe Martínez,

Watch time: 5m 9s
image

Felipe Martínez,

Watch time: 5m 9s
ESC 2016: New Drugs For The Management Of Chronic Heart Failure

Felipe Martínez,

Watch time: 3m 47s

Articles by Felipe Martínez

When Should We Start Sodium–Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention

Moritake Iguchi, Hiromichi Wada, Felipe Martínez, et al

Published:

Citation: European Cardiology Review 2023;18:e41.

DOI:

https://doi.org/10.15420/ecr.2022.62
Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project

Ricardo Lopez Santi, Felipe Martínez, Adrian Baranchuk, et al

Published:

Citation: European Cardiology Review 2021;16:e16.

DOI:

https://doi.org/10.15420/ecr.2020.42
Novel Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease: What Cardiologists and Diabetologists Should Know

Felipe Martínez,

Published:

Citation: European Cardiology Review 2021;16:e12.

DOI:

https://doi.org/10.15420/ecr.2020.38
Chagas Disease and Heart Failure: An Expanding Issue Worldwide

Felipe Martínez, Eduardo Perna, Sergio V Perrone, et al

Published:

Citation: European Cardiology Review 2019;14(2):82–8

DOI:

https://doi.org/10.15420/ecr.2018.30.2
Sodium–Glucose Co-transporter 2 Inhibitors in Heart Failure: Recent Data and Implications for Practice

Giuseppe Rosano, David Quek, Felipe Martínez, et al

Published:

Citation: Cardiac Failure Review 2020;6:e31.

DOI:

https://doi.org/10.15420/cfr.2020.23